Dr. Tapas Patra
MSc - Microbiology (2004), PhD - Molecular Microbiology (2012) | Post Doctoral Scientist
22 years of experience
MSc - Microbiology (2004), PhD - Molecular Microbiology (2012) | Post Doctoral Scientist
Dr. Tapas Patra, Ph.D., is a Scientist and Principal Investigator in the Department of Molecular Oncology at Sri Shankara Cancer Hospital & Research Centre, Bangalore. With a Ph.D. in Molecular Immunology from ICMR–National Institute for Research in Bacterial Infection (under Jadavpur University), Kolkata, he brings over 13 years of rich research experience across premier institutions in India and the USA. His distinguished career includes key positions at the National Institute of Pathology, IISER Mohali, Chittaranjan National Cancer Institute, and Saint Louis University, where he significantly advanced molecular and translational cancer research.
Dr. Patra’s expertise spans immuno-oncology, cancer metabolism, immunotherapy, and chemo-resistance, with a strong focus on gastrointestinal-hepatobiliary cancers and platinum resistance in ovarian cancer. His work explores the immunological and molecular mechanisms driving cancer initiation and progression, contributing to innovative therapeutic strategies. He also holds a patent for a Hepatitis C virus mRNA vaccine and has made impactful contributions to COVID-19 research, including studies referenced in international treatment discussions. With 28 peer-reviewed publications in high-impact journals—many as corresponding or co-first author—he has established himself as a leading voice in translational oncology.
An active academician and scientific leader, Dr. Patra serves on the editorial boards of multiple reputed international journals and is a life member of several prestigious scientific societies, including the Indian Immunology Society and the Indian Science Congress Association. Fluent in English, Hindi, and Bengali, he is available for consultations and research collaborations from Monday to Saturday (9:00 am to 6:00 pm) at the 1st Floor, Sharada Krupa Building. Guided by a vision to achieve breakthrough discoveries that directly benefit cancer patients, Dr. Patra remains deeply committed to advancing precision oncology and improving patient outcomes.